17Beta-estradiol confers a protective effect against transforming growth factor-beta2-induced cataracts in female but not male lenses

Experimental Eye Research

Volumn 78, Issue 1, 2004, Pages 67-74

  Chen, Zhengguang ^a   John, Molykutty ^a   Subramanian, Saradha ^a   Chen, Hong ^a   Carper, Deborah ^a  

^a NATIONAL EYE INSTITUTE   (United States)

Author keywords

17beta estradiol; Alpha smooth muscle actin; Anterior subcapsular cataract; Gene expression; Lens; Transforming growth factor beta

Indexed keywords

ALPHA ACTIN; ESTRADIOL; TRANSFORMING GROWTH FACTOR BETA2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATARACT; CONTROLLED STUDY; FEMALE; GENDER; GENE EXPRESSION; GENE INDUCTION; GENETIC TRANSCRIPTION; INCUBATION TIME; LENS; MALE; NONHUMAN; OVARIECTOMY; PREDICTION; PRIORITY JOURNAL; PROPHYLAXIS; PROTECTION; RAT; SEX DIFFERENCE; SMOOTH MUSCLE;

EID: 0345550319     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2003.09.015     Document Type: Article

References (31)

1. Apple D.J., Solomon K.D., Tetz M.R., Assia E.I., Holland E.Y., Legler U.F., Tsai J.C., Castaneda V.E., Hoggatt J.P., Kostick A.M. Posterior capsule opacification. Surv. Ophthalmol. 37:1992;73-116.
2. Benitez del Castillo J.M., del Rio T., Garcia-Sanchez J. Effects of estrogen use on lens transmittance in postmenopausal women. Ophthalmology. 104:1997;970-973.
3. Bigsby R.M., Cardenas H., Caperell-Grant A., Grubbs C.J. Protective effects of estrogen in a rat model of age-related cataracts. Proc. Nat. Acad. Sci. USA. 96:1999;9328-9332.
4. Davis V.L., Chan C.C., Schoen T.J., Couse J.F., Chader G.J., Korach K.S. An estrogen receptor repressor induces cataract formation in transgenic mice. Proc. Nat. Acad. Sci. USA. 99:2002;9427-9432.
5. Duncan G., Wormstone I.M., Liu C.S., Marcantonio J.M., Davies P.D. Thapsigargin-coated intraocular lenses inhibit human lens cell growth. Nat. Med. 3:1997;1026-1028.
6. Freeman E.E., Munoz B., Schein O.D., West S.K. Hormone replacement therapy and lens opacities: the Salisbury Eye Evaluation project. Arch. Opthalmol. 119:2001;1687-1702.
7. Green W.R., McDonnell P.J. Opacification of the posterior capsule Trans. Ophthalmol. Soc. UK. 104:1985;727-739.
8. Hales A.M., Chamberlain C.G., McAvoy J. Cataract induction in lenses cultured with transforming growth factor-β Invest. Ophthalmol. Vis. Sci. 36:1995;1709-1713.
9. Hales A.M., Chamberlain C.G., McAvoy J.W. Susceptibility of TGFbeta2-induced cataract increases with aging in the rat. Invest. Ophthalmol. Vis. Sci. 41:2000;3544-3551.
10. Hales A.M., Chamberlain C.G., Murphy C.R., McAvoy J.W. Estrogen protects lenses against cataract induced by transforming growth factor-β (TGFβ). J. Exp. Med. 185:1997;273-280.
11. Harding J.J. Estrogens and cataract. Arch. Ophthalmol. 112:1994;1511.
12. Hatae T., Ishibashi T., Yoshitomi F., Shibata Y. Immunocytochemistry of types I-IV collagen in human anterior subcapsular cataracts. Graefes Arch. Clin. Exp. Ophthalmol. 231:1993;586-590.
13. Hiller R., Sperduto R.D., Ederer F. Epidemiologic associations with nuclear, cortical, and posterior subcapsular cataracts. Am. J. Epidemiol. 124:1986;916-925.
14. Kappelhof J.P., Vrensen G.F. The pathology of after-cataract. A mini review. Acta Ophthalmol. Suppl. 1992;13-24.
15. Kim J.-T., Lee D.H., Chung K.-H., Kang I.-C., Kim D.-S., Joo C.-K. Inhibitory effects of salmosin, a disintegrin, on posterior capsular opacification in vitro and in vivo. Exp. Eye Res. 74:2002;585-594.
16. Klein B.E.K., Klein R., Linton K.L.P. Prevalence of age-related lens opacities in a population. The Beaver Dam study. Ophthalmology. 99:1992;546-552.
17. Klein B.E.K., Klein R., Ritter L.L. Is there evidence of an estrogen effect on age-related lens opacities? Arch. Ophthalmol. 112:1994;85-91.
18. Lee E.H., Joo C.K. Role of transforming growth factor-beta in transdifferentiation and fibrosis of lens epithelial cells. Invest. Ophthalmol. Vis. Sci. 40:1999;2025-2032.
19. Leske M.C., Connell A.M.S., Wu S., Hyman L., Schachat A. Prevalence of lens opacities in the Barbados eye study. Arch. Ophthalmol. 115:1997;105-111.
20. Liu J., Hales A.M., Chamberlain C.G., McAvoy J.W. Induction of cataract-like changes in rat lens epithelial explants by transforming growth factor β Invest. Ophthalmol. Vis. Sci. 35:1994;388-401.
21. Lovicu F.J., Schulz M.W., Hales A.H., Vincent L.N., Overbeek P.A., Chamberlain C.G., McAvoy J.W. TGFβ induces morphological and molecular changes similar to human anterior subscapsular cataract. Br. J. Ophthalmol. 86:2002;220-226.
22. Marcantonio J.M., Vrensen G.F. Cell biology of posterior capsular opacification. Eye. 13:1999;484-488.
23. Nishi O., Nishi K., Mano C., Ichihara M., Honda T., Saitoh I. Inhibition of migrating lens epithelial cells by blocking the adhesion molecule integrin: a preliminary report. J. Cataract Refract. Surg. 23:1997;860-865.
24. Schmitt-Graff A., Pau H., Spahr R., et al. Appearance of alpha-smooth muscle actin in human eye lens cells of anterior capsular cataract and in cultured bovine lens-forming cells. Differentiation. 43:1990;115-122.
25. Schwab I.R., Armstrong M.A., Friedman L.F., Wong I.G., Carpantieri A.C., Dawson C.R. Cataract extraction. Risk factors in a health maintenance organization population under 60 years of age. Arch. Ophthalmol. 106:1988;1062-1065.
26. Sun J.K., Iwata T., Zigler J.S. Jr., Carper D.A. Differential gene expression in male and female rat lenses undergoing cataract induction by transforming growth factor-β (TGF-β). Exp. Eye Res. 70:2000;169-181.
27. Wang X., Simpkins J.W., Dykens J.A., Cammarata P.R. Oxidative damage to human lens epithelial cells in culture: estrogen protection of mitochondrial potential, ATP, and cell viability. Invest. Ophthalmol. Vis. Sci. 44:2003;2067-2075.
28. Wormstone I.M., Del Rio-Tsonis K., McMahon G., Tamiya S., Davies P.D., Marcantonio J.M., Duncan G. FGF: an autocrine regulator of human lens cell growth independent of added stimuli. Invest. Ophthalmol. Vis. Sci. 42:2001;1305-1311.
29. Wormstone I.M., Tamiya S., Anderson I., Duncan G. TGF-beta2-induced matrix modification and cell transdifferentiation in the human lens capsular bag. Invest. Ophthalmol. Vis. Sci. 43:2002;2301-2308.
30. Worzala K., Hiller R., Sperduto R.D., Mutalik K., Murabito J.M., Moskowitz M., D'Agostino R.B., Wilson P.W. Postmenopausal estrogen use, type of menopause, and lens opacities: the Framingham studies. Arch. Intern. Med. 161:2001;1448-1454.
31. Younan C., Mitchell P., Cumming R.G., Panchapakesan J., Rochtchina E., Hales A.M. Hormone replacement therapy, reproductive factors, and the incidence of cataract and cataract surgery: the Blue Mountains Eye study. Am. J. Epidemiol. 155:2002;997-1006.